During your initial week, Dr
Toxicol Appl Pharmacol 285(2):136148 McKinsey TA, Foo R, Anene-Nzelu CG, Travers JG, Vagnozzi RJ, Weber N, Thum T (2022) Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development
What data or evidence do we need to get these discoveries from bench to bedside faster, while prioritizing safety, efficacy, and effectiveness? - Alexa Woodward, PhD, Senior Director of Strategic Accounts at HealthVerity Nearly every major manufacturer is investing in obesity pipelines, including combination therapies that target multiple pathways
To fully appreciate its significance, it's beneficial to understand the intricate cellular processes it influences
Gary: I think its hard to tell